This is the fifth of our video posts on 10 questions that can help lawyers contribute to the digital health ideation process.  Today’s video explores the question: who will pay for the offering?

Tags: Data Security, digital health, FDA, Health data, Medical Devices, Mobile Medical Apps
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Maree Gallagher Maree Gallagher

Maree Gallagher is an Irish qualified solicitor who advises clients on EU food and life sciences law and policy. She was elected President of the British Irish Chamber of Commerce for 2022/2023.

Maree has over twenty years of experience working with companies to…

Maree Gallagher is an Irish qualified solicitor who advises clients on EU food and life sciences law and policy. She was elected President of the British Irish Chamber of Commerce for 2022/2023.

Maree has over twenty years of experience working with companies to bring their products to market. She is regarded as one of Europe’s leading crisis management experts and has extensive experience advising FMCG companies on product recall and reputation management across the EU.

Maree’s expertise covers drugs and devices with a particular emphasis on biologics and GxP, food and beverages, AGRI, and consumer products. Her practice covers a very wide spectrum from product licensing to composition, labelling, and marketing. Her clients include large public companies as well as multinationals operating in the Life Sciences and FMCG sector across Ireland and the EU. Chambers Global listed Maree as a “Notable Practitioner” in their 2021 Guide to Crisis & Risk Management.

Maree also represents businesses facing regulatory enforcement action and she acts as a strategic and public affairs adviser in her specialist areas.

Read more about Maree GallagherEmail
Show more Show less
Photo of Rujul Desai Rujul Desai

Rujul Desai advises clients on drug pricing, market access, reimbursement, strategic contracting, and regulatory solutions for drugs, biologicals, devices, and diagnostics. He brings deep experience with biopharma, specialty pharmacy, and pharmacy benefit management (PBM) companies.

Rujul has held a number of leadership roles…

Rujul Desai advises clients on drug pricing, market access, reimbursement, strategic contracting, and regulatory solutions for drugs, biologicals, devices, and diagnostics. He brings deep experience with biopharma, specialty pharmacy, and pharmacy benefit management (PBM) companies.

Rujul has held a number of leadership roles in the biopharma, PBM, and specialty pharmacy industry, including with CVS Caremark, UCB, and most recently as Vice President at Avalere Health. He has led engagements across a wide range of U.S. and global market access and reimbursement issues, including optimizing new product launches, pricing, PBM and payer formulary access, value-based contracting, distribution network design, patient access and hub services, affordability programs, e-prescribing, digital health, and the use of health economic data and modeling.

Rujul is an author of the U.S. chapter of a global treatise on drug pricing and reimbursement.

Rujul was a Captain in the Medical Services Corps of the U.S. Army Reserves, and served in active duty in Iraq.

Read more about Rujul DesaiEmail
Show more Show less